Growth Metrics

Fulgent Genetics (FLGT) Cash from Financing Activities (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Cash from Financing Activities for 10 consecutive years, with -$534000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 63.3% to -$534000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.8 million through Dec 2025, down 205.12% year-over-year, with the annual reading at -$14.8 million for FY2025, 205.12% down from the prior year.
  • Cash from Financing Activities hit -$534000.0 in Q4 2025 for Fulgent Genetics, down from -$445000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $47.3 million in Q1 2021 to a low of -$35.5 million in Q3 2022.
  • Historically, Cash from Financing Activities has averaged -$3.0 million across 5 years, with a median of -$1.9 million in 2024.
  • Biggest five-year swings in Cash from Financing Activities: soared 47376.27% in 2021 and later crashed 1086.42% in 2022.
  • Year by year, Cash from Financing Activities stood at $13.2 million in 2021, then crashed by 324.97% to -$29.6 million in 2022, then rose by 12.31% to -$26.0 million in 2023, then surged by 98.74% to -$327000.0 in 2024, then tumbled by 63.3% to -$534000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for FLGT at -$534000.0 in Q4 2025, -$445000.0 in Q3 2025, and -$2.6 million in Q2 2025.